Journals / Turkish journal of nephrology (Online) / 2021 / Cilt: 30 - Sayı: 1

Is There a Role of ADAMTS-1 in Cyst Development in Autosomal Dominant Polycystic Kidney Disease?

Pages
25–29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further detailed studies are needed on the possible role of other ADAMTS family members in the remodeling of the extracellular matrix in ADPKD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease.
📊
Key Findings & Data:We investigated blood and urine levels of A Disintegrin and Metallo proteinase with Thrombospondin motifs 1 (ADAMTS-1) in patients with ADPKD to evaluate the possible role of ADAMTS-1 in cyst development.
💡
Conclusion & Impact:Further detailed studies are needed on the possible role of other ADAMTS family members in the remodeling of the extracellular matrix in ADPKD.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease. It is characterized by the development of multiple bilateral cysts that cause enlargement of the kidney. The underlying mecha nisms related with renal cyst development in ADPKD have been tried to be explained by cellular hyperproliferation, epithe lial fluid secretion, and extracellular matrix remodeling. All cystic disorders have some extracellular matrix abnormalities, but data about this step are limited in the literature. We investigated blood and urine levels of A Disintegrin and Metallo proteinase with Thrombospondin motifs 1 (ADAMTS-1) in patients with ADPKD to evaluate the possible role of ADAMTS-1 in cyst development. Materials and Methods: A case-control study was conducted in a training and research hospital. A total of 58 patients with ADPKD and 29 healthy volunteers were recruited. Serum and urine ADAMTS-1 levels were determined using a human en zyme-linked immunoassay in all subjects. Results: The serum ADAMTS-1 concentrations were lower in the ADPKD group than in the controls, but the difference was not statistically significant (p=0.653). The urine ADAMTS-1 levels were also not statistically different between the groups (p=0.921). Conclusion: This is the first study to investigate the role of ADAMTS in kidney disease in humans. In contrast to animal studies, the role of ADAMTS-1 in the extracellular matrix remodeling phase of cyst development is not apparent. Further detailed studies are needed on the possible role of other ADAMTS family members in the remodeling of the extracellular matrix in ADPKD.

🔖

Cite This Article

KARAKÖSE, S., KURTGÖZ, P. Ö., DENİZ, Ç. D., ERKUŞ, E., GÜNEY, İ. (2021). Is There a Role of ADAMTS-1 in Cyst Development in Autosomal Dominant Polycystic Kidney Disease?. Turkish journal of nephrology (Online), Cilt: 30 - Sayı: 1, 25–29. https://ajindex.com/articles/374826

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Malekshahabi T, Khoshdel Rad N, Serra AL, Moghadasali R. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions. J Cell Physiol 2019
  2. 12451-70. [Crossref] 2. Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers 2018
  3. [Crossref] 3. Colbert GB, Elrggal ME, Gaur L, Lerma EV. Update and review of adult polycystic kidney disease. Dis Mon 2020
  4. 100887. [Crossref] 4. Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: core Curriculum 2016. Am J Kidney Dis 2016
  5. [Crossref] 5. Aguiari G, Catizone L, Del Senno L. Multidrug therapy for polycystic kidney disease: a review and perspective. Am J Nephrol 2013
  6. [Crossref] 6. Ghata J, Cowley BD Jr. Polycystic Kidney Disease American Physiological Society. Compr Physiol 2017
  7. [Crossref] 7. Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol 2015
  8. [Crossref] 8. Stanton H, Melrose J, Little CB, Fosang AJ. Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta 2011
  9. [Crossref] 9. Dubail J, Apte SS. Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. Matrix Biol 2015
  10. [Crossref] 10. Vazquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999
  11. 23349-57. [Crossref] 11. Thai SN, Iruela-Arispe ML. Gene expression pattern Expression of ADAMTS1 during murine development. Mech Dev 2002
  12. [Crossref] 12. Mittaz L, Russell DL, Wilson T, Brasted M, Tkalcevic J, Salamonsen LA, et al. Adamts-1 ıs essential for the development and function of the urogenital system. Biol Reprod 2004
  13. [Crossref] 13. Mittaz L, Ricardo S, Martinez G, Kola I, Kelly DJ, Little MH, et al. Neonatal calyceal dilation and renal fibrosis resulting from loss of Adamts-1 in mouse kidney is due to a developmental dysgenesis. Nephrol Dial Transplant 2005
  14. [Crossref] 14. Perrone RD, Malek AM, Watnick T. Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2015
  15. [Crossref] 15. Lozano-Vilardell P, Lara-Hernández R, Benabarre-Castany N, García-García D. Abdominal aortic aneury